Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome

Gastroenterology

Volumn 141, Issue 5, 2011, Pages 1638-1647.e7

  Wong, Banny S ^a   Camilleri, Michael ^a   Busciglio, Irene ^a   Carlson, Paula ^a   Szarka, Lawrence A ^a   Burton, Duane ^a   Zinsmeister, Alan R ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b Mayo Clinic   (United States)

Author keywords

Clinical Trial; Drug Metabolism; Motor; Sensory

Indexed keywords

ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; DRONABINOL; FATTY ACID AMIDASE;

ADULT; ARTICLE; COLON MOTILITY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRY EYE; FATIGUE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HEADACHE; HEART RATE; HOT FLUSH; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; NAUSEA; PHARMACOGENETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORIMOTOR FUNCTION; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; XEROSTOMIA;

EID: 80054862795     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.07.036     Document Type: Article

References (9)

1. Storr M, Emmerdinger D, Diegelmann J, et al. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS One 2010;5:e9453.
2. Martinez-Gras I, Hoenicka J, Ponce G, et al. (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci 2006;256:437-441. (Pubitemid 44584060)
3. Ballon N, Leroy S, Roy C, et al. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenom J 2006;6:126-130.
4. Barrero FJ, Ampuero I, Morales B, et al. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J 2005;5:135-141. (Pubitemid 40468120)
5. Comings DE, Muhleman D, Gade R, et al. Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry 1997;2:161-168. (Pubitemid 27166036)
6. Tsai SJ, Wang YC, Hong CJ. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr Genet 2000;10:149-151.
7. Tiwari AK, Zai CC, Likhodi O, et al. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in schizophrenia. Neuropsychopharmacology 2010;35:1315-1324.
8. Vazquez-Roque MI, Camilleri M, Vella A, et al. Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil. 2011;23:637e257.
9. Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 2005;22:667-683. (Pubitemid 41475329)